candesartan has been researched along with Brain Injury, Vascular in 1 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Candesartan promotes angiogenesis and activates MMPs." | 1.42 | Sequential Therapy with Minocycline and Candesartan Improves Long-Term Recovery After Experimental Stroke. ( Fagan, SC; Fouda, AY; Ishrat, T; Patel, A; Pillai, B; Soliman, S, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Soliman, S | 1 |
| Ishrat, T | 1 |
| Fouda, AY | 1 |
| Patel, A | 1 |
| Pillai, B | 1 |
| Fagan, SC | 1 |
1 other study available for candesartan and Brain Injury, Vascular
| Article | Year |
|---|---|
Sequential Therapy with Minocycline and Candesartan Improves Long-Term Recovery After Experimental Stroke.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Brain Infarcti | 2015 |